Swansea Bay University Health Board

Management of oesophago-gastric cancer patients

Time period: 2020-2022
Organisation National
Number of oesophago-gastric (OG) cancer patients in audit 192 19,865
Case ascertainment for OG cancer (%) 85-100%
Method of Diagnosis
– Patients diagnosed after an emergency admission**
** Percent figure accounts for differences in mix of patients across organisations
39 20.5% 13.1%
– Patients with referral source reported as unknown 0 0.0% 1.4%
Pre-treatment staging of cancer
– Patients having staging CT scan recorded 186 96.9% 94.0%
Treatment planning
– Patients having a plan for curative treatment 49 25.5% 37.2%
– Patients having a plan for non-curative treatment 143 74.5% 62.8%
– Patients with non-curative plans having chemotherapy or radiotherapy 59 41.3% 34.7%

Outcomes for OG cancer patients who have curative surgery

Time period: 2019-2022
Organisation National
Number of patients having surgery 11 5452
Length of stay, median (days) N/A 10
Operations in which 15 or more lymph nodes were examined (%) 90.1%
30-day postoperative mortality (%) 1.5%
90-day postoperative mortality (%) 2.9%
Oesophageal surgery
Number of patients having oesophageal surgery N/A N/A
Oesophageal patients with positive longitudinal margins (%) 4.9%
Oesophageal patients with positive circumferential margins (%) 21.5%
Gastric surgery
Number of patients having gastric surgery N/A N/A
Gastric patients with positive longitudinal margins (%) 9.8%

Compare trust outcomes

Download this data as a PDF